US 7161003
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted A61PA61P35/00A61P35/02
Quick answer
US patent 7161003 (Pyrazolopyrimidines as cyclin dependent kinase inhibitors) held by Pharmacopeia Drug Discovery, Inc. expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmacopeia Drug Discovery, Inc.
- Grant date
- Tue Jan 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P35/04